BD Sells $750M in Notes | GenomeWeb

NEW YORK (GenomeWeb News) – Becton Dickinson has sold $750 million worth of new notes and intends to use the proceeds to repay outstanding notes, contribute to its pension plan, and for general corporate purposes, which may include acquisitions.

The firm sold $500 million worth of 5 percent notes due May 15, 2019, and it sold $250 million worth of notes due May 15, 2039. After underwriting discounts and commissions, BD estimated that its net proceeds would be around $738 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.